BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)

CUSIP: 07725L102

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+23,071
SEC-reported price per share
$365.94
Number of holders
26
Value change
+$8,510,428
Number of buys
17
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,486,061,718

Security key

07725L102

Report period

Q3 2026

Institutions

26

Top holders

10

Ownership snapshot

Top reported holders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
3/15
Latest evidence
14 Sep 2026
13D/G 3/4/5 13F Lead comparable stake: 7.8% 12 rows are not safely comparable across share classes. 13D/G row: BAKER BROS. ADVISORS LP Showing 1-6 of 15 holder rows.

Quick read

BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 7.8%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership Top 3
BAKER BROS. ADVISORS LP 7.8%
HHLR ADVISORS, LTD. 4.9%
Capital International Investors 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAKER BROS. ADVISORS LP
13D/G 3/4/5 13F
Julian C. Baker · Director · Company
7.8%
Reported 13D/G · 14 Sep 2026
$43,405,871,459
115,912,814 shares
$0 14 Sep 2026
HHLR ADVISORS, LTD.
3/4/5 13D/G
10%+ Owner
4.9%
Reported 13D/G · 09 May 2025
$25,009,148,200
125,045,741 shares
— 02 Dec 2024
Capital International Investors
13F 13D/G
Company
4.2%
Reported 13D/G · 31 Mar 2026
$1,201,254,811
4,210,221 shares
— 30 Jun 2026
AMGEN INC
3/4/5
10%+ Owner
—
denominator unverified
$3,419,356,261
18,943,802 shares
— 10 Sep 2021
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
—
denominator unverified
$1,427,110,097
5,007,931 shares
— 30 Jun 2026
FMR LLC
13F
Company
13F
—
denominator unverified
$706,305,845
2,478,527 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
26
Shares
42,064
Rows available
26
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
281
Q3 2026 holders
26
Holder diff
-255
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .